Pescadillo ribosomal biogenesis factor 1 and programmed death-ligand 1 in gastric and head and neck squamous cell carcinoma

Table 1 Expression of pescadillo ribosomal biogenesis factor 1 and programmed death-ligand 1 in gastric cancer and head and neck squamous cell cancer tissues

	Negatives	Positive
PES1	28 (48.28)	30 (51.72)
PD-L1	24 (41.38)	34 (58.62)

Data are presented as n (%). PES1: Pescadillo ribosomal biogenesis factor 1; PD-L1: Programmed death-ligand 1.

Table 2 Relationship between pescadillo ribosomal biogenesis factor 1 expression and clinical features of gastric cancer and head and neck squamous cell carcinoma

Diagnostic trait	n	PES1		χ2	P value
		Negative (n = 28)	Positive (n = 30)
Sex				0.222	0.637
Male	37	17 (45.95)	20 (54.05)
Women	21	11 (52.38)	10 (47.62)
Age (years)				0.210	0.647
< 60	41	19 (46.34)	22 (53.66)
≥ 60	17	9 (52.94)	8 (47.06)
Degree of differentiation				0.672	0.412
Poorly differentiated	32	17 (53.13)	15 (46.88)
Moderately to well differentiated	26	11 (42.31)	15 (57.69)
TNM staging				8.312	0.004
I-II	28	19 (67.86)	9 (32.14)
III	30	9 (30.00)	21 (70.00)
Lymphatic node transfer				5.287	0.021
Yes	39	15 (38.46)	24 (61.54)
No	19	13 (68.42)	6 (31.58)
Infiltration depth				6.846	0.009
T1/T2	25	17 (68.00)	8 (32.00)
T3/T4	33	11 (33.33)	22 (66.67)
Tumor diameter (cm)				0.485	0.486
< 5	41	21 (51.22)	20 (48.78)
≥ 5	17	7 (41.18)	10 (58.82)
Diabetes				0.021	0.885
Yes	15	7 (46.67)	8 (53.33)
No	43	21 (48.84)	22 (51.16)

Data are presented as n (%). PES1: Pescadillo ribosomal biogenesis factor 1.

Table 3 Relationship between programmed death-ligand 1 expression and clinical characteristics of gastric cancer and head and neck squamous cell carcinoma

Diagnostic trait	n	PD-L1		χ2	P value
		Negative (n = 24)	Positive (n = 34)
Sex				0.879	0.349
Male	37	17 (45.95)	20 (54.05)
Women	21	7 (33.33)	14 (66.67)
Age (years)				0.367	0.545
< 60	41	18 (43.90)	23 (56.10)
≥ 60	17	6 (35.29)	11 (64.71)
Degree of differentiation				6.508	0.011
Poorly differentiated	32	18 (56.25)	14 (43.75)
Moderately to well differentiated	26	6 (23.08)	20 (76.92)
TNM staging				0.049	0.825
I-II	28	12 (42.86)	16 (57.14)
III	30	12 (40.00)	18 (60.00)
Lymphatic node transfer				5.525	0.019
Yes	39	12 (30.77)	27 (69.23)
No	19	12 (63.16)	7 (36.84)
Infiltration depth				9.269	0.002
T1/T2	25	16 (64.00)	9 (36.00)
T3/T4	33	8 (24.24)	25 (75.76)
Tumor diameter (cm)				0.000	0.984
< 5	41	17 (41.46)	24 (58.54)
≥ 5	17	7 (41.18)	10 (58.82)
Diabetes				1.192	0.275
Yes	15	8 (53.33)	7 (46.67)
No	43	16 (37.21)	27 (62.79)

Data are presented as n (%). PD-L1: Programmed death-ligand 1.